TipRanks
Matinas BioPharma (MTNB)
XASE:MTNB
US Market
MTNB
Matinas BioPharma
RESEARCH TOOLSreports
Want to see MTNB full AI Analyst Report?

Matinas BioPharma (MTNB) Income Statement

1,545 Followers

Matinas BioPharma Income Statement

Last quarter (Q2 2026), Matinas BioPharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Matinas BioPharma's net income was $-1.33M. See Matinas BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 1.10M$ 3.19M$ 33.00K
Gross Profit
$ -456.00K$ -972.00K$ 155.00K$ -13.49M$ -14.55M
Operating Expenses
$ 6.50M$ 19.19M$ 23.92M$ 11.10M$ 10.19M
Depreciation and Amortization
$ 456.00K$ 972.00K$ 941.00K$ 356.00K$ 280.00K
EBITDA
$ -9.89M$ -19.19M$ -22.00M$ -20.64M$ -23.00M
Operating Income
$ -6.96M$ -20.16M$ -23.77M$ -24.59M$ -24.73M
Other Income/Expenses
$ -3.38M$ -4.17M$ 824.00K$ 3.59M$ 1.45M
Pretax Income
$ -10.35M$ -24.33M$ -22.94M$ -21.00M$ -23.28M
Net Income
$ -10.35M$ -24.25M$ -22.94M$ -21.00M$ -23.28M
Per Share Metrics
Basic EPS
$ -30.00$ -74.70$ -79.20$ -45.00$ -75.60
Diluted EPS
$ -30.00$ -74.70$ -79.20$ -45.00$ -75.60
Weighted Average Shares Outstanding
 364.94K 324.39K 289.69K 289.08K 280.24K
Weighted Average Shares Outstanding (Diluted)
 364.94K 324.39K 289.69K 289.08K 280.24K
Currency in USD

Matinas BioPharma Earnings and Revenue History